Cameron Durrant

Cameron Durrant founded PediatRx, Inc. in 2010, where he worked as Chief Executive & Financial Officer & Director from 2010 to 2012, Quint Media, Inc. in 2005, where he worked as Chairman, President, CEO, CFO & Treasurer from 2012 to 2013, and Taran Pharma Ltd. in 2014, where he is working as Chairman & Chief Executive Officer from 2014.
Dr. Durrant also founded Prism Pharmaceuticals, Inc. Dr. Durrant also currently works at Humanigen, Inc., as Chairman, CAO, Chief Executive & Financial Officer from 2022, Alcyone Therapeutics, Inc., as Director, Bexion Pharmaceuticals, Inc., as Director from 2013, Pressure Point, Inc., as Director, and Royal College of General Practitioners, as Member.
Dr. Durrant also formerly worked at Spherics, Inc., as President & Chief Executive Officer in 2007, Striker Energy Corp., as President & Chief Executive Officer in 2010, PediaMed Pharmaceuticals, Inc., as President & Chief Executive Officer in 2006, E.
Claiborne Robins Co., Inc., as President & Chief Executive Officer from 2012 to 2014, ECR Pharmaceuticals Co., Inc., as President & Chief Executive Officer from 2012 to 2014, Anavex Life Sciences Corp., as Executive Chairman in 2010, Topaz Pharmaceuticals, Inc., as Director, PDS Operating Corp., as Director, Immune Pharmaceuticals, Inc., as Independent Director from 2014 to 2015, Reliefband Technologies LLC, as Director, Johnson & Johnson, as VP-Worldwide Global Strategic Marketing in 2009, Merck & Co., Inc., as Global Vice President-Infectious Diseases, GSK Plc, as Global Vice President-Infectious Diseases, and Pharmacia Corp., as Global Vice President-Infectious Diseases.
Dr. Durrant received his Masters Business Admin degree from Henley Management College and doctorate degree from Cardiff University School of Medicine.